Clinical Trial Update: Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis [Phase 2]

View source ↗

Summary

This Phase 2 study update reports long-term safety of adding teriflunomide to interferon-beta or glatiramer acetate in patients with multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• GLATIRAMER ACETATE (GLATIRAMER ACETATE)
• Interferon-beta (interferon beta)
• Teriflunomide (teriflunomide)

Snippet

Sponsor: Sanofi | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2012-12-31